Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
CompletedNot applicableNCT05914311
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
During the typical SCS trial the leads remain outside of the skin and can be prone to migration. The leads are typically secured in place with suture, tape, or a combination of both. This study will evaluate the amount of movement based on the method of being secured at the time of placement
Study details
- Official title
- Use of Dermabond in Mitigation of Spinal Cord Stimulation Trial Lead Migration
- Conditions
- Interventions
- Device: Suture
- Device: Suture and Dermabond
- Sponsor
- Wake Forest University Health Sciences
- Start date
- 2023-09-08
- Primary completion
- 2025-02-26
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * age greater than 18 * having a spinal cord stimulator trial lead placement done * lead placement to be done in the thoracic spine area Exclusion Criteria: * dermabond allergy * inability to place 2 leads in subject * lead placement not in thoracic spine
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05914311